| scholarly article | Q13442814 |
| P50 | author | Sean P Sherman | Q55189936 |
| P2093 | author name string | Jie Lu | |
| April D Pyle | |||
| Jeffrey I Zink | |||
| Daniel P Ferris | |||
| Fuyuhiko Tamanoi | |||
| Courtney R Thomas | |||
| Rolando E Yanes | |||
| Angela A Hwang | |||
| Derrick Tarn | |||
| P2860 | cites work | Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain | Q22009364 |
| Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems | Q28238785 | ||
| Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus | Q28258751 | ||
| Synaptotagmin VII regulates Ca(2+)-dependent exocytosis of lysosomes in fibroblasts | Q28577830 | ||
| Palmitoylation-dependent association with CD63 targets the Ca2+ sensor synaptotagmin VII to lysosomes | Q28591116 | ||
| Exo1: a new chemical inhibitor of the exocytic pathway | Q30478301 | ||
| Actin Filaments and Myosin I Alpha Cooperate with Microtubules for the Movement of Lysosomes | Q30856974 | ||
| Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells | Q33220776 | ||
| Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery | Q33407563 | ||
| Resistance to Tumor Necrosis Factor-Induced Cell Death Mediated by PMCA4 Deficiency | Q34012937 | ||
| Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals | Q34188389 | ||
| Membrane repair: Ca 2+ -elicited lysosomal exocytosis | Q34453029 | ||
| Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium | Q34866369 | ||
| Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves | Q35049783 | ||
| Circulation of Cholesterol between Lysosomes and the Plasma Membrane | Q74785529 | ||
| cAMP regulates Ca2+-dependent exocytosis of lysosomes and lysosome-mediated cell invasion by trypanosomes | Q77841141 | ||
| U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells | Q78109239 | ||
| Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells | Q79358978 | ||
| Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells | Q81307606 | ||
| Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT | Q83008501 | ||
| Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate | Q83149823 | ||
| Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer | Q35144398 | ||
| Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells | Q35162222 | ||
| Destination 'lysosome': a target organelle for tumour cell killing? | Q35549436 | ||
| In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification | Q35566413 | ||
| The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. | Q35779648 | ||
| Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells | Q36274042 | ||
| Luminescent silica nanobeads: characterization and evaluation as efficient cytoplasmatic transporters for T-lymphocytes | Q36876504 | ||
| Mesoporous materials for drug delivery. | Q36939951 | ||
| Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers | Q37178442 | ||
| Light-activated nanoimpeller-controlled drug release in cancer cells | Q37266438 | ||
| Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line | Q37507270 | ||
| Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. | Q37529131 | ||
| Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells | Q37655405 | ||
| Development of Mesoporous Silica Nanomaterials As a Vehicle for Anticancer Drug Delivery | Q38002853 | ||
| Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding | Q38314227 | ||
| Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. | Q38497007 | ||
| Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy | Q39351898 | ||
| Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery | Q39436022 | ||
| Mannose‐Functionalized Mesoporous Silica Nanoparticles for Efficient Two‐Photon Photodynamic Therapy of Solid Tumors | Q39462712 | ||
| Intracellular pH‐Responsive Mesoporous Silica Nanoparticles for the Controlled Release of Anticancer Chemotherapeutics | Q39652008 | ||
| Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. | Q39672199 | ||
| The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function | Q39792101 | ||
| Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles | Q39795401 | ||
| Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs | Q40120393 | ||
| Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells | Q42410638 | ||
| Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells | Q42646371 | ||
| Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. | Q42809063 | ||
| Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging | Q42949516 | ||
| Preconditioning-induced cytoprotection in hepatocytes requires Ca(2+)-dependent exocytosis of lysosomes | Q44768493 | ||
| Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. | Q45934786 | ||
| Colloidal suspensions of functionalized mesoporous silica nanoparticles | Q46126739 | ||
| Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. | Q46460939 | ||
| Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. | Q47415510 | ||
| Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism | Q56864699 | ||
| Differential effects of brefeldin A on transport of secretory and lysosomal proteins | Q57075848 | ||
| Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting. | Q64996492 | ||
| P433 | issue | 5 | |
| P921 | main subject | nanoparticle | Q61231 |
| exocytosis | Q323426 | ||
| drug delivery | Q1392806 | ||
| P304 | page(s) | 697-704 | |
| P577 | publication date | 2012-11-14 | |
| P1433 | published in | Small | Q3486838 |
| P1476 | title | Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition | |
| P478 | volume | 9 |
| Q41600610 | A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores |
| Q35009134 | A reversible light-operated nanovalve on mesoporous silica nanoparticles. |
| Q57688652 | A versatile drug delivery system targeting senescent cells |
| Q88554461 | Alveolar epithelial cell processing of nanoparticles activates autophagy and lysosomal exocytosis |
| Q38557213 | An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects |
| Q48163518 | Boosting the therapeutic efficiency of nanovectors: exocytosis engineering. |
| Q38786580 | Breakable mesoporous silica nanoparticles for targeted drug delivery |
| Q38557482 | Cellular uptake of nanoparticles: journey inside the cell. |
| Q92883550 | Controlling Localization and Excretion of Nanoparticles by Click Modification of the Surface Chemical Structures inside Living Cells |
| Q47359221 | Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications |
| Q55692299 | Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance. |
| Q91619354 | Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles |
| Q39120055 | Enzyme-Catalyzed Conversion of Chemical Structures on the Surface of Gold Nanorods |
| Q38852801 | Excess titanium dioxide nanoparticles on the cell surface induce cytotoxicity by hindering ion exchange and disrupting exocytosis processes. |
| Q38874863 | Immunogold labeling reveals subcellular localisation of silica nanoparticles in a human blood-brain barrier model |
| Q55222222 | Intra-mitochondrial biomineralization for inducing apoptosis of cancer cells. |
| Q58759012 | Mesenchymal stem cells loaded with paclitaxel-poly(lactic--glycolic acid) nanoparticles for glioma-targeting therapy |
| Q42151859 | Multifunctional Gold-Mesoporous Silica Nanocomposites for Enhanced Two-Photon Imaging and Therapy of Cancer Cells. |
| Q38586843 | Nanotoxicology: advances and pitfalls in research methodology |
| Q64107133 | Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems |
| Q37134029 | Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery |
| Q35795900 | Rapid endosomal escape of prickly nanodiamonds: implications for gene delivery. |
| Q92135261 | Role of Cellular Retention and Intracellular State in Controlling Gene Delivery Efficiency of Multiple Nonviral Carriers |
| Q57367659 | Silica-based multifunctional nanodelivery systems toward regenerative medicine |
| Q59737298 | Sugar and pH dual-responsive mesoporous silica nanocontainers based on competitive binding mechanisms |
| Q58549968 | The challenges of oral drug delivery via nanocarriers |
| Q42544597 | The role of surface functionality in nanoparticle exocytosis. |
| Q57832986 | The role of surface functionalization of silica nanoparticles for bioimaging |
| Q37670239 | Unambiguous observation of shape effects on cellular fate of nanoparticles. |
Search more.